Device Type ID | 320 |
Device Name | Radioimmunoassay, Estradiol |
Regulation Description | Estradiol Test System. |
Regulation Medical Specialty | Clinical Chemistry |
Review Panel | Clinical Chemistry |
Premarket Review | Office Of In Vitro Diagnostics And Radiological Health (OIR) |
Submission Type | 510(K) Exempt |
CFR Regulation Number | 862.1260 [🔎] |
FDA Device Classification | Class 1 Medical Device |
Product Code | CHP |
GMP Exempt | No |
Summary MR | Eligible |
Implanted Device | No |
Life Support Device | No |
Third Party Review | Not Third Party Eligible |
Device Type ID | 320 |
Device | Radioimmunoassay, Estradiol |
Product Code | CHP |
FDA Device Classification | Class 1 Medical Device |
Regulation Description | Estradiol Test System. |
CFR Regulation Number | 862.1260 [🔎] |
Device Problems | |
---|---|
Adverse Event Without Identified Device Or Use Problem | 24 |
High Test Results | 22 |
Incorrect, Inadequate Or Imprecise Result Or Readings | 17 |
Low Test Results | 13 |
Incorrect Or Inadequate Test Results | 7 |
Mechanical Problem | 7 |
No Apparent Adverse Event | 7 |
Calibration Problem | 4 |
Non Reproducible Results | 3 |
Appropriate Term/Code Not Available | 2 |
Insufficient Information | 2 |
Probe | 1 |
Unable To Obtain Readings | 1 |
Device Damaged Prior To Use | 1 |
Cell | 1 |
Mixer | 1 |
Wire | 1 |
Device Operational Issue | 1 |
Total Device Problems | 115 |
Recalls | |||
---|---|---|---|
Manufacturer | Recall Class | Date Posted | |
1 | Abbott Ireland Diagnostics Division | II | Dec-22-2018 |
2 | Abbott Laboratories | II | May-31-2016 |
3 | BioMerieux SA | II | Mar-20-2017 |
4 | Diasorin Inc. | II | Nov-21-2016 |
5 | ORTHO-CLINICAL DIAGNOSTICS | II | Aug-05-2016 |
6 | Roche Diagnostics Operations, Inc. | II | Mar-31-2016 |
7 | Siemens Healthcare Diagnostics, Inc | II | Feb-04-2018 |
8 | Siemens Healthcare Diagnostics, Inc | II | Mar-24-2016 |
9 | Siemens Healthcare Diagnostics, Inc. | II | Jul-13-2018 |
10 | Siemens Healthcare Diagnostics, Inc. | II | May-05-2017 |
11 | Tosoh Bioscience Inc | II | Jun-05-2018 |